<p><strong>Other fibrates &amp; HMG CoA reductase inhibitors</strong>: As Risk of myopathy, rhabdomyolysis and myoglobinuria may be increased if Ciprofbrate is used in combination with other fibrates and HMG CoA reductase inhibitors.<br />
<br />
<strong>Oral anticoagulant therapy</strong>: Caution should be exercised when Ciprofbrate is taken with oral anticoagulants. Concomitant oral anticoagulant therapy should be given at a reduced dosage and adjusted according to INR.</p>